Creating a new test for quickly diagnosing syphilis at the clinic
Development of a novel syphilis molecular diagnostic assay for a point-of-care multiplexed genital ulcer panel test on giant magnetoresistive biosensors
This study is working on a quick and easy test for syphilis that can be done right in the doctor's office, so patients can get their results and treatment faster, without needing special lab equipment.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Magic Lifescience, INC. NIH-funded |
| Lab location | 1 site (Mountain View, United States) |
| Project ID | NIH-10978102 on NIH RePORTER |
What this research studies
This research aims to develop a fast and effective point-of-care test for diagnosing both congenital and adult-acquired syphilis. Current testing methods are slow and often require specialized lab equipment, which can delay treatment. The new test will utilize advanced biosensor technology to provide immediate results, allowing healthcare providers to offer timely treatment to patients. By focusing on the best sample types for testing, this project seeks to improve the accuracy and efficiency of syphilis diagnosis.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults and pregnant individuals who may be at risk for syphilis or have symptoms of genital ulcers.
Not a fit: Patients who are not at risk for syphilis or do not exhibit symptoms related to genital ulcers may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to quicker and more accurate syphilis diagnoses, improving patient outcomes and treatment efficiency.
How similar studies have performed: Other research has shown promise in using biosensor technology for rapid diagnostics, indicating that this approach could be effective.
Where this research is happening
Mountain View, United States
- Magic Lifescience, INC. — Mountain View, United States (Active)
Researchers
- Principal investigator: Ng, Elaine — Magic Lifescience, INC.
- Study coordinator: Ng, Elaine
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.